Recognition of Superpotent Sweetener Ligands by a Library of Monoclonal Antibodies
โ Scribed by Jerry M. Anchin; Srinivasan Nagarajan; Jeff Carter; Michael S. Kellogg; Grant E. DuBois; D. Scott Linithicum
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 116 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0952-3499
No coin nor oath required. For personal study only.
โฆ Synopsis
Monoclonal antibodies (mAb) made to the superpotent guanidino sweet tasting ligand, N-(p-cyanophenyl)-N-(diphenylmethyl)-guanidineacetic acid were examined for their molecular recognition specificities using 14 different sweetener analogues in a competitive radioimmunoassay. The effects of variations in pH on ligand binding was also examined by radioimmunoassay. Photoaffinity labelling of the binding site was accomplished using a radiolabelled azido-derivative of the parent ligand, and L-chain or H-chain labelling was easily identified in several different mAb. For two of the mAb examined in this study (NC6.8 and NC10.14), the analogue binding studies are in agreement with the known Fab-ligand crystal structures. Monoclonal antibodies to this family of sweet tasting compounds may be useful probes for the study of sweet taste chemistry and identification of novel sweet taste ligands from combinatorial chemical libraries.
๐ SIMILAR VOLUMES
## Abstract The energy landscape of the uranyl (UO~2~) chelate dissociated from a monoclonal antibody U08S was investigated using dynamic force spectroscopy (DFS). The uranyl ion (UO) is chelated with the ligand dicarboxyโphenanthroline (DCP). The monoclonal antibody U08S was raised against UO~2~โD
## Abstract Photolabeled monoclonal antibodies generated against a potent antagonist of the glycoprotein receptor GPIIbโIIIa have been used to demonstrate that antibodies can be employed to replace receptors for onโbead screening of combinatorial libraries.
Inhibition of hapten-specific cytotoxic T cell recognition by monoclonal
Tungsten microparticles may be introduced into some pre-filled syringes during the creation of the needle hole. In turn, these microcontaminants may interact with protein therapeutics to produce visible particles. We found that soluble tungsten polyanions formed in acidic buffer below pH 6.0 can pre